Serum KL-6 was found to be elevated in various interstitial lung diseases including IPF, nonspecific interstitial pneumonia (NSIP), collagen vascular disease-associated interstitial pneumonia (CVD-IP), and drug-induced and radiation-induced pneumonitis. The gene discussed is MUC1; the disease is incontinentia pigmenti.